Emitents | Olainfarm, AS (213800WCG52W62ENOP27) |
Veids | Citi |
Valoda | EN |
Statuss | Atcelts |
Versija | |
Datums | 2016-12-09 10:01:16 |
Versijas komentārs | |
Teksts |
Recording of the Third Quarter 2016 Investor Conference Webinar
On December 8 JSC „Olainfarm”
organized its Investor Conference Online Webinar. During the
webinar the member of the management board of JSC „Olainfarm”
Salvis Lapiņš analyzed the financial results of third quarter 2016
and informed about other recent activities within the company. The
turnover prognosis for 2016 have been adjusted to 9 MEUR instead of
previously announced 10 MEUR.
The recorded JSC “Olainfarm” webinar is available online:
http://ej.uz/OLF_Q3_2016_rec,
and the
presentation, demonstrated during the webinar, is available in the
previously published company’s announcement:
http://ej.uz/OLF_Q3_2016_PDF.
Olainfarm thanks all participants,
who joined the webinar, and encourages everybody to follow
company’s announcements to get information on the next webinar!
JSC Olainfarm is one of the
biggest pharmaceutical companies in Latvia with more than 40 years
of experience in production of medication and chemical and
pharmaceutical products. A basic principle of company's operations
is to produce reliable and effective top quality products for
Latvia and the rest of the world. Products made by the Group are
being exported to more than 35 countries of the world, including
the Baltics, Russia, other CIS, Europe, Asia, North America and
Australia. Information prepared by:
|
Pielikumi |
|